Recursion Provides Business Updates and Reports Fourth

Recursion, a clinical stage TechBio company leading the space by decoding biology to industrialise drug discovery, today reported business updates and financial results for its fourth quarter and fiscal year ending December 31, 2022. Here's what happened to the company.

Source: globenewswire.com
Published on 2023-02-27

« Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Quality - Driven ESG : Build Trust by Improving Data Quality »